Age at Diagnosis (years) | ||
 | Median | 68 |
Mean | 65 | |
Gender (n, %) | Â | |
 | Female | 58 (42%) |
Male | 81 (58%) | |
Ethnicity (n, %) | ||
 | Caucasian | 94 (67.6%) |
African American | 35 (25.2%) | |
Hispanic | 6 (4.3%) | |
Asian | 3 (2.2%) | |
Other | 1 (0.7%) | |
Smoking History At Diagnosis (n, %) | ||
 | Current Smoker | 56 (40.3%) |
Former Smoker | 72 (51.8%) | |
Never Smoker | 11 (7.91%) | |
Stage at Diagnosis (n, %) | ||
 | Stage Ia | 2 (1.4%) |
Stage IIa | 10 (7.2%) | |
Stage III | 54 (38.9%) | |
Stage IV | 72 (51.8%) | |
Other | 1 (0.7%) | |
Histopathology (n, %) | ||
 | Adenocarcinoma | 92 (66.2%) |
Squamous Cell | 42 (30.2%) | |
Large Cell | 2 (1.4%) | |
Other | 3 (2.2%) | |
Performance Status (n, %) | ||
 | 0 | 44 (31.6%) |
1 | 71 (51.1%) | |
2 | 21 (15.1%) | |
3 | 3 (2.2%) | |
4 | 0 (0%) |